PART 2: THE FILES THAT SHOULDN’T EXIST
The medicine cup felt heavier than it should.
Richard Hayes stood motionless in the hospital corridor, watching the little girl hold it as if it were the last thing connecting her to her mother.
Her fingers were small.
Trembling.
Careful not to spill the remaining trace of blue residue.
Dr. Evan Collins shifted uncomfortably behind them.
“We should really contact social services immediately,” he muttered.
But Richard wasn’t listening.
His eyes were locked on the cup.
On the drug.
On Remoria.
The most profitable product his company had ever released.
And the one he personally approved for global distribution.
The girl sniffed softly.
“Mom said the medicine was from your company.”
Richard finally spoke.
“Yes.”
The word came out slower than he expected.
The girl nodded like she already knew the answer.
Then she whispered,
“Then why didn’t it work?”
Silence dropped instantly into the hallway.
Even the fluorescent lights seemed louder.
Richard didn’t answer.
Because he couldn’t.
Instead, he turned to Dr. Collins.
“I want her file.”
The doctor blinked.
“What?”
“I want Maria Torres’ full medical file. Every record. Every note. Every test result.”
Collins hesitated.
“That’s… not something you can just—”
Richard stepped closer.
“I didn’t ask if it was easy.”
A long pause.
Then the doctor exhaled.
“…I’ll see what I can do.”
Forty minutes later.
Hospital archive room.
Cold air.
Metal cabinets.
Stacks of sealed folders.
Dr. Collins placed a thin file on the table.
Maria Torres.
Patient ID: 88-417.
Richard opened it.
At first, everything looked normal.
Diagnosis: late-stage lymphoma.
Treatment plan: experimental drug Remoria.
Dosage logs.
Progress charts.
Initial improvement noted.
Then—
A sudden plateau.
Then decline.
Richard flipped the page faster.
And faster.
Until he stopped.
His expression changed.
Subtle at first.
Then sharp.
“What is this?” he asked quietly.
Collins didn’t respond immediately.
Richard pointed at the page.
“These numbers don’t match the published trial results.”
The doctor swallowed.
“They… should.”
Richard looked up.
“Explain.”
Silence.
Then Collins finally spoke.
“This version of the data… isn’t public.”
Richard froze.
“…What do you mean, not public?”
Collins looked away.
“There were two trial datasets.”
Richard felt something cold crawl up his spine.
“Two?”
The doctor nodded slowly.
“One submitted for approval.”
A pause.
“And one… kept internal.”
Richard turned another page.
His eyes scanned rapidly.
Then stopped again.
A list of patients.
Dozens of names.
Marked with outcomes.
Some labeled response positive.
Some labeled partial response.
And some—
Marked only with a single word.
“DECEASED.”
Richard’s grip tightened on the folder.
“This is falsified reporting.”
Collins didn’t deny it.
That was the answer.
Richard’s voice dropped.
“How many people were in the internal dataset?”
The doctor hesitated.
“…More than the public trial.”
“HOW MANY?”
Collins finally answered.
“Three times more.”
Silence again.
Richard leaned back slowly.
For the first time in years, he felt something unfamiliar.
Not anger.
Not confusion.
Something worse.
Certainty.
The girl’s voice echoed in his mind.
Did it save anyone?
He closed the file.
“Who approved this submission?”
Collins didn’t speak.
Richard pressed harder.
“Who signed off on the public data?”
A long pause.
Then—
One name.
A name Richard knew very well.
Chief Research Director.
Dr. Helen Marsh.
Richard stood still.
That name wasn’t just an employee.
She was the architect of Remoria.
The face of its success.
The woman who stood beside him at press conferences.
The woman who promised the world this drug was “safe and life-extending.”
Richard slowly exhaled.
“Bring her in.”
Collins shook his head slightly.
“She’s not at the hospital.”
“Then find her.”
Another pause.
Then Collins added quietly:
“She resigned yesterday.”
That stopped Richard completely.
“Resigned?”
“Yes.”
Richard looked down at the file again.
Something didn’t add up.
Too many coincidences.
Too clean.
Too fast.
He turned toward the door.
“Pull every internal communication from the last six months.”
Collins hesitated.
“That would require board authorization.”
Richard’s eyes hardened.
“I am the board.”
Later that night.
Richard’s private office.
City lights flickered outside the glass walls.
Stacks of documents spread across the desk.
Emails.
Trial logs.
Financial reports.
Redacted safety warnings.
And one final document marked:
“CONFIDENTIAL — INCIDENT REPORT 14B”
Richard opened it.
And stopped breathing.
Inside were reports of patient deaths.
Not one.
Not two.
Dozens.
All showing the same pattern.
Initial improvement.
Then sudden collapse.
Organ failure.
Unexplained complications.
All linked to Remoria.
Richard leaned forward slowly.
His voice barely a whisper.
“This… was never released.”
A soft knock came at the door.
He didn’t look up.
“Come in.”
Dr. Collins entered hesitantly.
“There’s something else you should see.”
He placed another file on the desk.
This one thicker.
Heavier.
Older.
Richard opened it.
And froze.
At the top of the page was a handwritten note:
“DO NOT DISCLOSE TO OUTSIDE REVIEW — PROJECT SILENT GATE”
Richard’s face tightened.
“What is Silent Gate?”
Collins hesitated.
“…The internal cover protocol.”
Richard looked up slowly.
“Cover what?”
The doctor didn’t answer.
But the silence did.
And in that silence, Richard Hayes finally understood something terrifying:
Remoria was not just a failed drug.
May you like
It was a controlled secret.
And Maria Torres… was only the beginning of the story someone had tried very hard to bury.
